aTyr Pharma reported $2.86M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Ardelyx USD 129.36M 107.08M Sep/2025
aTyr Pharma USD 2.86M 126.59K Sep/2025
Biogen USD 2.21B 64.9M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Galapagos EUR 22.95M 15.57M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Grifols EUR 3.56B 63.19M Dec/2024
Novartis USD 6.42B 114M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
United Therapeutics USD 176.5M 7.3M Sep/2025